Exane BNP Paribas Downgrades AstraZeneca (AZN) to Neutral

September 13, 2016 12:55 PM EDT
Get Alerts AZN Hot Sheet
Price: $27.16 +3.39%

Rating Summary:
    13 Buy, 7 Hold, 4 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade AZN Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Exane BNP Paribas downgraded AstraZeneca (NYSE: AZN) from Outperform to Neutral.

For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.

Shares of AstraZeneca closed at $33.24 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Add Your Comment